The Trump administration’s recent spending bill has resulted in a significant defunding of Planned Parenthood, specifically excluding the organization from Medicaid reimbursement due to its provision of abortion care, despite the Hyde Amendment of 1977 prohibiting federal funding for abortions. This “defunding” is currently held in abeyance by an injunction, but it is set to take effect once that legal barrier is removed.

In a conversation with the leadership at Planned Parenthood of Orange and San Bernardino Counties (PPOSBC), new data highlights the potentially devastating impact this defunding could have on pregnant women and their babies in the region.

Contrary to claims by Republican lawmakers that the move is rooted in “pro-family” values, the projected effects reveal a stark reality: nearly 100,000 women may be deprived of opt-out screenings for syphilis and trichomoniasis, both common sexually transmitted infections (STIs) that often present no symptoms in their early stages. These infections can lead to severe complications during pregnancy, including preterm birth and serious health issues in newborns.

Since April 2021, PPOSBC has implemented an “opt-out” screening strategy for syphilis and other STIs across its nine health centers. This innovative approach has allowed the organization to offer STI testing to all 130,000 patients annually as part of routine appointments, thus facilitating early detection of syphilis cases and preventing congenital syphilis, which can result in neurological damage and other severe medical conditions for infants.

The program has proven effective, prompting PPOSBC to expand its testing to include trichomoniasis in November 2024. This addition allowed healthcare providers to identify hundreds of cases in pregnant women that might have otherwise gone unnoticed. Without timely intervention, trichomoniasis can exacerbate the risks of premature labor and low birth weight, along with the danger of transmitting the infection to newborns.

To date, the opt-out model has led to the identification of 396 cases of trichomoniasis in pregnant women, constituting 17% of all positive cases screened through the program since July 2024.

As this situation unfolds, it remains crucial to understand the broader implications of these funding changes on health services for women and children in the community, as well as the long-term effects on the overall health of mothers and infants.